Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul A Carpenter

Showing results (61-70 of 178) with videos related to

Pageof 18
Sort By:
Bone Marrow Transplantation|February 21, 2024
Return to school practices after hematopoietic cell transplantation: a survey of transplant centers in the United StatesNeel S Bhatt, Christa L Meyer, Lih-Wen Mau, et al.
Blood|April 3, 2013
Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host diseaseYoshihiro Inamoto, Barry E Storer, Effie W Petersdorf, et al.
Transplantation and Cellular Therapy|June 19, 2022
Neuropathy and Muscle Cramps in Autologous and Allogeneic Hematopoietic Cell Transplantation SurvivorsTanya Lehky, Iago Pinal Fernandez, Elizabeth F Krakow, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 19, 2007
Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host diseaseKikuchi Takahide, Pablo M Parker, Michael Wu, et al.
Blood|June 3, 2011
Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantationYoshihiro Inamoto, Mary E D Flowers, Stephanie J Lee, et al.
American Journal of Hematology|July 1, 2026
Clinical Predictors of Response in Chronic Graft-Versus-Host Disease: Results From the "Predicting the Quality of Response to Specific Treatments (PQRST)" TrialBetty K Hamilton, Lynn Onstad, Paul A Carpenter, et al.
Blood|May 13, 2017
An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host diseasePaul J Martin, Barry E Storer, Yoshihiro Inamoto, et al.
Transplantation and Cellular Therapy|June 28, 2025
American Society for Transplantation and Cellular Therapy Series #11: Updated Cytomegalovirus Guidelines in Hematopoietic Cell Transplant and Cellular Therapy RecipientsFareed Khawaja, Danniel Zamora, Michelle K Yong, et al.
Contemporary Clinical Trials|July 22, 2024
Study Protocol: Predicting the Quality of Response to Specific Treatments (PQRST) in Chronic Graft-versus-Host DiseaseBetty K Hamilton, Lynn Onstad, Paul A Carpenter, et al.
Transplantation and Cellular Therapy|September 4, 2022
Humoral and Cellular Immune Response to Covid-19 Vaccination in Patients with Chronic Graft-versus-Host Disease on ImmunosuppressionShivaprasad Manjappa, Huy Q Phi, Lik Wee Lee, et al.
Pageof 18

Showing results (61-70 of 178) with videos related to

Sort By:
Pageof 18
Bone Marrow Transplantation|February 21, 2024
Return to school practices after hematopoietic cell transplantation: a survey of transplant centers in the United StatesNeel S Bhatt, Christa L Meyer, Lih-Wen Mau, et al.
Blood|April 3, 2013
Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host diseaseYoshihiro Inamoto, Barry E Storer, Effie W Petersdorf, et al.
Transplantation and Cellular Therapy|June 19, 2022
Neuropathy and Muscle Cramps in Autologous and Allogeneic Hematopoietic Cell Transplantation SurvivorsTanya Lehky, Iago Pinal Fernandez, Elizabeth F Krakow, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 19, 2007
Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host diseaseKikuchi Takahide, Pablo M Parker, Michael Wu, et al.
Blood|June 3, 2011
Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantationYoshihiro Inamoto, Mary E D Flowers, Stephanie J Lee, et al.
American Journal of Hematology|July 1, 2026
Clinical Predictors of Response in Chronic Graft-Versus-Host Disease: Results From the "Predicting the Quality of Response to Specific Treatments (PQRST)" TrialBetty K Hamilton, Lynn Onstad, Paul A Carpenter, et al.
Blood|May 13, 2017
An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host diseasePaul J Martin, Barry E Storer, Yoshihiro Inamoto, et al.
Transplantation and Cellular Therapy|June 28, 2025
American Society for Transplantation and Cellular Therapy Series #11: Updated Cytomegalovirus Guidelines in Hematopoietic Cell Transplant and Cellular Therapy RecipientsFareed Khawaja, Danniel Zamora, Michelle K Yong, et al.
Contemporary Clinical Trials|July 22, 2024
Study Protocol: Predicting the Quality of Response to Specific Treatments (PQRST) in Chronic Graft-versus-Host DiseaseBetty K Hamilton, Lynn Onstad, Paul A Carpenter, et al.
Transplantation and Cellular Therapy|September 4, 2022
Humoral and Cellular Immune Response to Covid-19 Vaccination in Patients with Chronic Graft-versus-Host Disease on ImmunosuppressionShivaprasad Manjappa, Huy Q Phi, Lik Wee Lee, et al.
Pageof 18